The ascendancy of Viagra and its influence on the medicinal landscape presents a intricate question for traders. While the first sales data were impressive, the exclusivity has expired, leading to a deluge of generic alternatives that are chipping away at profit. In addition, the industry is facing issues related to aging trends and changing health